ARCHIVES

Control-Arm CML Patients In Phase III Gleevec Study Allowed To Switch.

This article is from The Cancer Letter archive.

Vol. 28 No. 04 | January 25, 2002

Download PDF Visit The Full Archive

Related Articles

IOM Calls for Freeze On Med School Classes, Cuts of Residencies

February 2, 1996

April issue of Business & Regulatory Report included (8 additional pages).

April 30, 2004

Breast Cancer Task Force Must Take More Active Role In RFP Development, New Chairman Insists

November 14, 1975

In Brief: Six On NCA Serve Out Terms, No Successors in Sights DCBD Renamed With ‘Centers’ In Title

February 9, 1990

In Brief: Columbia-Presbyterian Cancer center to Be Renamed After Donor Herbert Irving

December 6, 1996

Cancer Registry Says Paper By Jon Sudbo Was Based On Fabricated Data.

January 27, 2006